Tag Archives: Surprise

Kadmon’s Rezurock scores surprise FDA nod in chronic graft-versus-host-disease

With a surprise FDA approval Friday afternoon, Kadmon Holdings is on its way to becoming a commercial drugmaker.  The FDA cleared Kadmon’s Rezurock to treat chronic graft-versus-host disease, a serious complication of transplant procedures. Formerly known as belumodsil, the drug is a first-in-class ROCK2 inhibitor—and now Kadmon’s first approved drug.  GVHD occurs when donor cells mount an immune response against a patient’s own tissues and organs. While doctors can… Read More »

‘Ticks Surprise Us:’ 2021 May Be Big Lyme Disease Year

Bay Area Lyme Foundation: “Ticks Carrying Disease Found to be Abundant in Beach Areas, Similar to Woodlands, According to New Study.” Daniel Salkeld, PhD, research scientist, Colorado State University. John Aucott, MD, director, Johns Hopkins Lyme Disease Clinical Research Center. Kirsten Stein, board member, Bay Area Lyme Foundation. Weather.com: “It’s Been the Warmest Winter on… Read More »

Even Republicans Want to Outlaw Surprise Medical Billing

By BOB HERTZ On  April 3, the Secretary of Health and Human Services, Alex Azar, announced that the federal government would pick up the tab for testing and treating all uninsured Americans for COVID-19. Azar specifically promised that: a) hospitals would be paid the same prices they receive for Medicare patients; and b) hospitals which accept the… Read More »

In Fine Print, HHS Appears To Ban All Surprise Billing During The Pandemic

This story also ran on NPR. This story can be republished for free (details). Federal officials offering emergency funding to hospitals, clinics and doctors’ practices have included this stipulation: They cannot foist surprise medical bills on COVID-19 patients. But buried in the Department of Health and Human Services’ terms and conditions for eligibility is language… Read More »